List of Excipients in API valsartan oral
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing valsartan oral
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Advagen Pharma Ltd | valsartan oral | 72888-184 | METHYLPARABEN |
| Advagen Pharma Ltd | valsartan oral | 72888-184 | POLOXAMER 188 |
| Advagen Pharma Ltd | valsartan oral | 72888-184 | POTASSIUM SORBATE |
| Advagen Pharma Ltd | valsartan oral | 72888-184 | PROPYLENE GLYCOL |
| Advagen Pharma Ltd | valsartan oral | 72888-184 | SODIUM HYDROXIDE |
| Advagen Pharma Ltd | valsartan oral | 72888-184 | SUCRALOSE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for valsartan oral
Excipient focus: METHYLPARABEN
valsartan oral drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Advagen Pharma Ltd | valsartan oral | 72888-184 |
| >Company | >Ingredient | >NDC |
valsartan oral drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 188
valsartan oral drug variants containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| Advagen Pharma Ltd | valsartan oral | 72888-184 |
| >Company | >Ingredient | >NDC |
valsartan oral drug variants not containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM SORBATE
valsartan oral drug variants containing POTASSIUM SORBATE
| Company | Ingredient | NDC |
|---|---|---|
| Advagen Pharma Ltd | valsartan oral | 72888-184 |
| >Company | >Ingredient | >NDC |
valsartan oral drug variants not containing POTASSIUM SORBATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
valsartan oral drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Advagen Pharma Ltd | valsartan oral | 72888-184 |
| >Company | >Ingredient | >NDC |
valsartan oral drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
valsartan oral drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Advagen Pharma Ltd | valsartan oral | 72888-184 |
| >Company | >Ingredient | >NDC |
valsartan oral drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
valsartan oral drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Advagen Pharma Ltd | valsartan oral | 72888-184 |
| >Company | >Ingredient | >NDC |
valsartan oral drug variants not containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
valsartan oral drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Advagen Pharma Ltd | valsartan oral | 72888-184 |
| >Company | >Ingredient | >NDC |
valsartan oral drug variants not containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
valsartan oral drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Advagen Pharma Ltd | valsartan oral | 72888-184 |
| >Company | >Ingredient | >NDC |
valsartan oral drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
